The university is arguing that the judge had no basis to compel arbitration of what Cornell is claiming is a fraudulent settlement.
Cornell claims that it was fraudulently induced into settling a patent-infringement lawsuit it filed with Life Tech against Illumina.
The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.
In PLOS this week: plague patterns in Kyrgyzstan, trypanosomiasis susceptibility variants, and more.
Among the winners are a number of investigators who will receive funding to support omics-focused research.
The funding will support three research centers and a data management and coordinating center investigating myalgic encephalomyelitis/chronic fatigue syndrome.
The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.
Genetically modified diamondback moths are being tested in upstate New York, according to the Atlantic.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
Gene drives might run into biological resistance, the Economist reports.
The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.
A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.
Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.
In Science this week: analysis of DNA from ancient North Africans, and more.